drugset / Trial / NCT00296855

Comparison Study of Vasovist® Magnetic Resonance Angiography (MRA) and an MRA With a Conventional Extracellular Contrast Agent With X-ray Angiography in Patients With Peripheral Artery Disease

NCT00296855

Phase 3 Completed 261 enrolled Bayer
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

The particular aim of this study is the comparison of the diagnostic results of MRA images upon application of Vasovist (gadofosveset), a contrast agent not yet available on the market, with the MRA images upon application of a conventional extracellular contrast agent. A catheter angiography, which will be performed as a routine diagnostic procedure for vascular diseases, will serve as an evaluation standard.

Timeline

Start
2006-02
Primary completion
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Vasovist Diagnostic / imaging agent 0.03 unknown Intravenous